Table 2.
Neuropathological Details of the Control, MCI, and EAD Subjects
| Subjects | DP | Neuritic plaque | Neurofibrillary tangles |
|---|---|---|---|
| Control for EAD IPL-1 | 3 | 7.59 | 0.4 |
| Control for EAD IPL-2 | 0 | 0 | 0 |
| Control for EAD IPL-3 | 0.2 | 0.2 | 0 |
| Control for EAD IPL-4 | 27.39 | 11 | 0 |
| EAD 1 | 48.4 | 12.39 | 1.39 |
| EAD 2 | 50 | 9.19 | 2.79 |
| EAD 3 | 20 | 9.19 | 4.59 |
| EAD 4 | 8.19 | 6.19 | 0.6 |
| Control for MCI-IPL-1 | 41.59 | 7.8 | 0 |
| Control for MCI-IPL-2 | 0 | 0 | 0 |
| Control for MCI-IPL-3 | 0 | 0 | 0 |
| Control for MCI-IPL-4 | 39.79 | 16.2 | 0 |
| Control for MCI-IPL-5 | 0 | 0 | 0 |
| Control for MCI-IPL-6 | 0 | 0 | 0 |
| MCI-IPL-1 | 4.4 | 11.39 | 0 |
| MCI-IPL-2 | 50 | 22 | 0 |
| MCI-IPL-3 | 0.2 | 5 | 0 |
| MCI-IPL-4 | 49 | 14.19 | 0 |
| MCI-IPL-5 | 50 | 16.2 | 0 |
| MCI-IPL-6 | 50 | 18.2 | 0 |